Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Am J Kidney Dis. 2013 Aug;62(2):322-30. doi: 10.1053/j.ajkd.2013.03.011. Epub 2013 May 13.
Bloodstream infections (BSIs) cause substantial morbidity in hemodialysis patients. In 2009, the US Centers for Disease Control and Prevention (CDC) sponsored a collaborative project to prevent BSIs in outpatient hemodialysis facilities. We sought to assess the impact of a set of interventions on BSI and access-related BSI rates in participating facilities using data reported to the CDC's National Healthcare Safety Network (NHSN).
Quality improvement project.
SETTING & PARTICIPANTS: Patients in 17 outpatient hemodialysis facilities that volunteered to participate.
Facilities reported monthly event and denominator data to NHSN, received guidance from the CDC, and implemented an evidence-based intervention package that included chlorhexidine use for catheter exit-site care, staff training and competency assessments focused on catheter care and aseptic technique, hand hygiene and vascular access care audits, and feedback of infection and adherence rates to staff.
Crude and modeled BSI and access-related BSI rates.
Up to 12 months of preintervention (January 2009 through December 2009) and 15 months of intervention period (January 2010 through March 2011) data from participating centers were analyzed. Segmented regression analysis was used to assess changes in BSI and access-related BSI rates during the preintervention and intervention periods.
Most (65%) participating facilities were hospital based. Pooled mean BSI and access-related BSI rates were 1.09 and 0.73 events per 100 patient-months during the preintervention period and 0.89 and 0.42 events per 100 patient-months during the intervention period, respectively. Modeled rates decreased 32% (P = 0.01) for BSIs and 54% (P < 0.001) for access-related BSIs at the start of the intervention period.
Participating facilities were not representative of all outpatient hemodialysis centers nationally. There was no control arm to this quality improvement project.
Facilities participating in a collaborative successfully decreased their BSI and access-related BSI rates. The decreased rates appeared to be maintained in the intervention period. These findings suggest that improved implementation of recommended practices can reduce BSIs in hemodialysis centers.
血流感染(BSI)会给血液透析患者带来严重的发病率。2009 年,美国疾病控制与预防中心(CDC)发起了一项合作项目,旨在预防门诊血液透析机构中的 BSI。我们试图利用向 CDC 的国家医疗保健安全网络(NHSN)报告的数据,评估一套干预措施对参与机构的 BSI 和与通路相关的 BSI 发生率的影响。
质量改进项目。
自愿参与的 17 家门诊血液透析机构的患者。
机构每月向 NHSN 报告事件和分母数据,接受 CDC 的指导,并实施一套基于证据的干预措施包,包括用氯己定进行导管出口部位护理、针对导管护理和无菌技术、手卫生和血管通路护理审计的员工培训和能力评估,以及将感染和依从率反馈给员工。
原始和建模的 BSI 和与通路相关的 BSI 率。
分析了参与中心的多达 12 个月的干预前(2009 年 1 月至 2009 年 12 月)和 15 个月的干预期(2010 年 1 月至 2011 年 3 月)的数据。使用分段回归分析评估了干预前和干预期间 BSI 和与通路相关的 BSI 率的变化。
大多数(65%)参与的机构是医院为基础的。在干预前期间, pooled 平均 BSI 和与通路相关的 BSI 率分别为每 100 个患者月 1.09 和 0.73 例,而在干预期间分别为每 100 个患者月 0.89 和 0.42 例。在干预开始时,BSI 模型化的速率下降了 32%(P=0.01),与通路相关的 BSI 下降了 54%(P<0.001)。
参与的机构不能代表全国所有的门诊血液透析中心。这个质量改进项目没有对照组。
参与合作的机构成功降低了他们的 BSI 和与通路相关的 BSI 率。在干预期间,这些降低的比率似乎得到了维持。这些发现表明,推荐实践的改进实施可以减少血液透析中心的 BSI。